Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1322 |
|---|---|
| Identifier | NCT05197049 |
| Trial Title | A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Guselkumab Dose 1|DRUG: Guselkumab Dose 2|DRUG: Guselkumab Dose 3|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2022-01-19 |
|---|---|
| Primary Completion Date | 2023-07-04 |
| Completion Date | 2028-10-30 |